IDEAYA Biosciences Doses First Patient in a Phase 1 Combination Study of IDE196 and Binimetinib, a MEK Inhibitor

News
2020
2019
Archive

June 3, 2020

Aprea Therapeutics Completes Full Enrollment of Phase 3 Clinical Trial in TP53 Mutant Myelodysplastic Syndromes (MDS)
May 29, 2020

Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases
May 28, 2020

Rallybio Further Broadens Drug Development Capabilities with Addition of Róisín Armstrong, PhD
May 28, 2020

Cabaletta Bio Announces Expansion of Sponsored Research Agreement with the University of Pennsylvania
May 27, 2020

Biodesy Announces Corporate Name Change to BlueLight Therapeutics
May 26, 2020

Vor Biopharma Adds to Leadership Team with Appointment of Chief Financial Officer
May 26, 2020

Homology Medicines Announces Peer-Reviewed Publication Describing Molecular Characterization of Precise In Vivo Nuclease-Free Gene Editing with PKU Program
May 21, 2020

scPharmaceuticals Announces Pricing of Public Offering of Common Stock
May 20, 2020

CanSino Biologics and Precision NanoSystems Announce Collaboration to Co-Develop a COVID-19 RNA Vaccine
May 20, 2020

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation